443 related articles for article (PubMed ID: 2572488)
21. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
Wilson ES; Cruickshank J; McMaster M; Weir RJ
Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
[TBL] [Abstract][Full Text] [Related]
22. A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids.
Stanczyk FZ; Brenner PF; Mishell DR; Ortiz A; Gentzschein EK; Goebelsmann U
Contraception; 1978 Dec; 18(6):615-33. PubMed ID: 750188
[TBL] [Abstract][Full Text] [Related]
23. Oral contraceptive potencies and side effects.
Berger GS; Talwar PP
Obstet Gynecol; 1978 May; 51(5):545-7. PubMed ID: 349438
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a new triphasic oral contraceptive in private practice.
Ellsworth HS; Ayerst RI; Harris JW; Stone RA; Anderson AE; Jones TL; Curtis MK
Contraception; 1986 Nov; 34(5):435-42. PubMed ID: 3102161
[TBL] [Abstract][Full Text] [Related]
25. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
Akerlund M; Røde A; Westergaard J
Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
[TBL] [Abstract][Full Text] [Related]
26. Effect of oral contraceptive agents on nutrients: II. Vitamins.
Prasad AS; Oberleas D; Moghissi KS; Stryker JC; Lei KY
Am J Clin Nutr; 1975 Apr; 28(4):385-91. PubMed ID: 1168019
[TBL] [Abstract][Full Text] [Related]
27. An assessment of the side effects of switching from one oral contraceptive to another.
Edelman DA; Kothenbeutel R; Levinski MJ; Talwar PP
Int J Gynaecol Obstet; 1976; 14(5):397-400. PubMed ID: 15904
[TBL] [Abstract][Full Text] [Related]
28. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
29. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
[TBL] [Abstract][Full Text] [Related]
30. Hormonal postcoital contraception with an ethinylestradiol-norgestrel combination and two danazol regimens.
Zuliani G; Colombo UF; Molla R
Eur J Obstet Gynecol Reprod Biol; 1990 Dec; 37(3):253-60. PubMed ID: 2227068
[TBL] [Abstract][Full Text] [Related]
31. Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.
Kirkman RJ; Pedersen JH; Fioretti P; Roberts HE
Contraception; 1994 Jan; 49(1):33-46. PubMed ID: 8137624
[TBL] [Abstract][Full Text] [Related]
32. A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception.
Contraception; 1980 May; 21(5):445-59. PubMed ID: 7428356
[TBL] [Abstract][Full Text] [Related]
33. Phasic contraceptive pills and functional ovarian cysts.
Caillouette JC; Koehler AL
Am J Obstet Gynecol; 1987 Jun; 156(6):1538-42. PubMed ID: 3296761
[TBL] [Abstract][Full Text] [Related]
34. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
35. Ovral as a "morning-after" contraceptive.
Med Lett Drugs Ther; 1989 Oct; 31(803):93-4. PubMed ID: 2796842
[TBL] [Abstract][Full Text] [Related]
36. The 150/30 formulation. Experience in the United Kingdom.
Guillebaud J
J Reprod Med; 1983 Jan; 28(1 Suppl):66-70. PubMed ID: 6403702
[TBL] [Abstract][Full Text] [Related]
37. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
38. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
[TBL] [Abstract][Full Text] [Related]
39. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.
Graham CA; Sherwin BB
J Psychosom Res; 1992 Apr; 36(3):257-66. PubMed ID: 1564678
[TBL] [Abstract][Full Text] [Related]
40. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]